Surf Therapeutics

AustinFounded 20228 employees

Medical Devices

Capital FactoryPartners Fund 2023

About

Surf Therapeutics is developing the first ultrasound neuromodulatory technology for the treatment of autoimmune disorders.

Team

ND

Nash D

founder

J

See something off about this company?

Joey

employee

Problem

About 2.5 million Americans are intolerant to or do not achieve remission with the currently available therapies. This leads to chronic pain, disability, and decreased longevity. The company is developing an at-home therapy device that can safely and effectively induce an anti-inflammatory effect to treat these patients.

Traction

Completed first in human study yielding very positive outcomes with statistically significant reduction in primary outcomes in treatment group vs sham group.

Recent press

Surf Therapeutics Reports Positive First-in-Human Data and Secures Additional Financing, Bringing Total Funding to $6M as Rheumatoid Arthritis Clinical Study Begins
BioSpace · Mar 18, 2026

Links

Website LinkedIn

Share this profile

Sign in to see contact details

Pitch deck

Surf Therapeutics Overview_CF.pdf

1.3 MB · Uploaded Apr 24, 2026

This pitch deck is for investors.

Sign in to view →

Sign in to see more details